| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |